Real-World Case Series of Omidubicel-Onlv for Allogeneic Transplantation in Patients with Hematologic Malignancies Using a Reduced Toxicity Myeloablative Conditioning Regimen
Conferences
Hong, S; Schwarzbach, A; Horwitz, M
Published in: TRANSPLANTATION AND CELLULAR THERAPY
February 2026
Duke Scholars
Altmetric Attention Stats
Dimensions Citation Stats
Published In
TRANSPLANTATION AND CELLULAR THERAPY
EISSN
2666-6367
ISSN
2666-6375
Publication Date
February 2026
Volume
32
Issue
2
Start / End Page
S134 / S134
Related Subject Headings
- Immunology
- 3201 Cardiovascular medicine and haematology
Citation
APA
Chicago
ICMJE
MLA
NLM
Hong, S., Schwarzbach, A., & Horwitz, M. (2026). Real-World Case Series of Omidubicel-Onlv for Allogeneic Transplantation in Patients with Hematologic Malignancies Using a Reduced Toxicity Myeloablative Conditioning Regimen. In TRANSPLANTATION AND CELLULAR THERAPY (Vol. 32, pp. S134–S134).
Hong, Sanghee, Aurelie Schwarzbach, and Mitchell Horwitz. “Real-World Case Series of Omidubicel-Onlv for Allogeneic Transplantation in Patients with Hematologic Malignancies Using a Reduced Toxicity Myeloablative Conditioning Regimen.” In TRANSPLANTATION AND CELLULAR THERAPY, 32:S134–S134, 2026.
Hong S, Schwarzbach A, Horwitz M. Real-World Case Series of Omidubicel-Onlv for Allogeneic Transplantation in Patients with Hematologic Malignancies Using a Reduced Toxicity Myeloablative Conditioning Regimen. In: TRANSPLANTATION AND CELLULAR THERAPY. 2026. p. S134–S134.
Hong, Sanghee, et al. “Real-World Case Series of Omidubicel-Onlv for Allogeneic Transplantation in Patients with Hematologic Malignancies Using a Reduced Toxicity Myeloablative Conditioning Regimen.” TRANSPLANTATION AND CELLULAR THERAPY, vol. 32, no. 2, 2026, pp. S134–S134.
Hong S, Schwarzbach A, Horwitz M. Real-World Case Series of Omidubicel-Onlv for Allogeneic Transplantation in Patients with Hematologic Malignancies Using a Reduced Toxicity Myeloablative Conditioning Regimen. TRANSPLANTATION AND CELLULAR THERAPY. 2026. p. S134–S134.
Published In
TRANSPLANTATION AND CELLULAR THERAPY
EISSN
2666-6367
ISSN
2666-6375
Publication Date
February 2026
Volume
32
Issue
2
Start / End Page
S134 / S134
Related Subject Headings
- Immunology
- 3201 Cardiovascular medicine and haematology